ENDI Corp. Announces Planned SEC Deregistration and Transfer of Trading to OTC Pink Market
January 12, 2024 17:00 ET
|
ENDI Corp.
Glen Allen, VA, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ENDI Corp. (OTCQB: ENDI) (“ENDI” or the “Company”) today announced its intention to deregister its Class A common stock under the Securities...
Byggmästare Anders J Ahlström Holding AB (publ): Ge-Te Media avyttrar SDR
December 15, 2023 14:30 ET
|
Byggmästare Anders J Ahlström Holding AB (publ)
Byggmästarens dotterföretag Ge-Te Media, där Byggmästaren äger ca 63 procent, har tecknat avtal om att avyttra SDR Svensk Direktreklam AB (”SDR”) till North Media A/S. SDR har en lång historik som...
Daxor Corporation to Present at the 13th Annual LD Micro Main Event 2020
December 09, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
New Research Shows Daxor’s BVA-100® Blood Test Provides Unique Benefit in Detecting Anemia and Heart Failure Risk, Presented at the Heart Failure Society of America Meeting 2020
October 06, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces Appointment of Henry D. Cremisi, MD, FACP and Joy Goudie, Esq. to the Company’s Board of Directors
June 30, 2020 08:00 ET
|
Daxor Corporation
NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor’s BVA-100® Published in Novel Study in American Heart Association Journal - Circulation
May 22, 2020 08:00 ET
|
Daxor Corporation
NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation’s BVA-100® Test Used to Guide Treatment In COVID-19 Patient
March 20, 2020 08:00 ET
|
Daxor Corporation
New Clinical Protocol for Volume-Guided Therapy Helps Combat Coronavirus NEW YORK, March 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative...
Daxor Corporation Announces Engagement with Hospitals and Government for Use of the Blood Volume Analyzer (BVA-100®) to Stem COVID-19 Deaths
March 02, 2020 08:00 ET
|
Daxor Corporation
NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2019
November 12, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
New Independent Data Further Demonstrates Clinical Utility of Daxor Corporation’s Blood Volume Analyzer (BVA-100) Over Surrogate Measurements
September 17, 2018 08:30 ET
|
Daxor Corporation
NEW YORK, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...